Pharmaceutical News

RSS

Lianhuaqingwen capsule is effective for treating COVID-19 pneumonia

Lianhuaqingwen (LHQW) capsule, a herb medicine product, has been clinically proved to be effective in coronavirus disease 2019 (COVID-19) pneumonia treatment. However, human exposure to LHQW components and their pharmacological effects remain largely unknown.

28 Oct 2020

Researchers develop a model to design vaccines, cancer immunotherapies

The body's immune system defeats diseases by sensing foreign invaders, like bacteria or viruses, and then mounting a response against them.

28 Oct 2020

FDA grants approval of nonprescription Sklice lotion to treat head lice infestations

Today, the U.S. Food and Drug Administration approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch.

27 Oct 2020

Phase II NRG Oncology trial evaluates two regimens for muscle-invasive bladder cancer

Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for selected patients with muscle-invasive bladder cancer.

27 Oct 2020

COVID-19 vaccine tracker provides real-time updates on effective vaccine

McGill University professor Nicole Basta and her team have created an interactive online COVID-19 vaccine tracker, that provides real-time updates on progress in developing a safe and effective vaccine.

27 Oct 2020

Potentially inappropriate medication prescribing linked with increased hospitalizations, costs

The prescription of potentially inappropriate medications to older adults is linked to increased hospitalizations, and it costs patients, on average, more than $450 per year, according to a new University at Buffalo study.

23 Oct 2020

Researchers create AI system that matches tumors to best drug combinations

Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).

23 Oct 2020

Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels

A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.

23 Oct 2020

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

22 Oct 2020

Common medication used to treat diabetic macular edema is less effective in Black patients

A medication frequently used to treat diabetic macular edema, which is the most common cause of blindness in people with diabetes, is less effective when used to treat the condition in Black patients, new study results show.

22 Oct 2020

New research highlights potential global hesitancy to accept a COVID-19 vaccine

A research team from the City University of New York Graduate School of Public Health and Health Policy, the Barcelona Institute for Global Health, the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, and Georgetown University Law School announced today that Nature Medicine has published their research revealing potential global hesitancy to accept a COVID-19 vaccine.

21 Oct 2020

Scientists suggest that anti-malarial drugs could be repurposed to treat COVID-19

An international group of researchers believe there is enough evidence that anti-malarial drugs could be repurposed to treat COVID-19 and that they should be assessed for efficacy in clinical trials.

20 Oct 2020

Study shows concerning levels of COVID-19 vaccine hesitancy

More than a third of people (34%) in Turkey and one sixth of people (17%) in the UK are 'hesitant' about a COVID-19 vaccine, according to a study by UCL and Dokuz Eylul University in Turkey.

20 Oct 2020

Microbiology expert examines antiviral activities of Respiratory Detox Shot

Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).

19 Oct 2020

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

A new study by UBC researchers is set to change international treatment recommendations for people who are newly diagnosed with HIV--an update that could affect nearly two million people per year worldwide.

19 Oct 2020

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

FDA warns women about the risks of using NSAIDs in the second half of pregnancy

The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring labeling changes for nonsteroidal anti-inflammatory drugs (NSAIDs).

15 Oct 2020

News coverage contributes to drug shortages in COVID-19

Researchers at Boston Children's Hospital in the U.S. have reported that the recent shortage of medicines used to treat coronavirus disease 2019 (COVID-19) could be due to extensive news media coverage that results in individual hoarding or institutional stockpiling of medicines.

15 Oct 2020

Certain live-attenuated vaccines can prevent severe complications of COVID-19

COVID-19 continues to wreak havoc globally, with over one million deaths to date. Yet what if an existing vaccine could make COVID-19 less deadly? A study just published put the theory to test, with promising results.

15 Oct 2020

Pharmacist-led digital intervention associated with reduced rates of hazardous prescribing

A pharmacist-led, new digital intervention that improves patient safety when prescribing medication in general practice reduced rates of hazardous prescribing by more than 40 per cent, 12 months after it had been introduced to 43 GP practices in Salford, finds a new study.

14 Oct 2020

Pharmaceutical News

Lianhuaqingwen capsule is effective for treating COVID-19 pneumonia

Researchers develop a model to design vaccines, cancer immunotherapies

FDA grants approval of nonprescription Sklice lotion to treat head lice infestations

Phase II NRG Oncology trial evaluates two regimens for muscle-invasive bladder cancer

COVID-19 vaccine tracker provides real-time updates on effective vaccine

Potentially inappropriate medication prescribing linked with increased hospitalizations, costs

Researchers create AI system that matches tumors to best drug combinations

Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels

First antiviral treatment for COVID-19 receives FDA approval

Common medication used to treat diabetic macular edema is less effective in Black patients

New research highlights potential global hesitancy to accept a COVID-19 vaccine

Scientists suggest that anti-malarial drugs could be repurposed to treat COVID-19

Study shows concerning levels of COVID-19 vaccine hesitancy

Microbiology expert examines antiviral activities of Respiratory Detox Shot

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

FDA warns women about the risks of using NSAIDs in the second half of pregnancy

News coverage contributes to drug shortages in COVID-19

Certain live-attenuated vaccines can prevent severe complications of COVID-19

Pharmacist-led digital intervention associated with reduced rates of hazardous prescribing

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News